The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oral Contraceptive-Global Market Insights and Sales Trends 2024
Synopsis
The global Oral Contraceptive market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oral Contraceptive in various end use industries. The expanding demands from the Male and Female, are propelling Oral Contraceptive market. Combination, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Progestin Only segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Contraceptive covered in this report include Pfizer, Inc., Bayer AG, Merck & Co., Inc., Janssen Global Services, LLC, Mankind Pharma Ltd., Teva Pharmaceutical Industries Ltd, Allergan, plc (Actavis), Piramal Enterprises Ltd. and Beijing Zizhu Pharm, etc.
The global Oral Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
Global Oral Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Contraceptive market, Segment by Type:
Combination
Progestin Only
Others
Global Oral Contraceptive market, by Application
Male
Female
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Oral Contraceptive market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oral Contraceptive in various end use industries. The expanding demands from the Male and Female, are propelling Oral Contraceptive market. Combination, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Progestin Only segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oral Contraceptive, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oral Contraceptive market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oral Contraceptive market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oral Contraceptive sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oral Contraceptive covered in this report include Pfizer, Inc., Bayer AG, Merck & Co., Inc., Janssen Global Services, LLC, Mankind Pharma Ltd., Teva Pharmaceutical Industries Ltd, Allergan, plc (Actavis), Piramal Enterprises Ltd. and Beijing Zizhu Pharm, etc.
The global Oral Contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer, Inc.
Bayer AG
Merck & Co., Inc.
Janssen Global Services, LLC
Mankind Pharma Ltd.
Teva Pharmaceutical Industries Ltd
Allergan, plc (Actavis)
Piramal Enterprises Ltd.
Beijing Zizhu Pharm
Global Oral Contraceptive market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oral Contraceptive market, Segment by Type:
Combination
Progestin Only
Others
Global Oral Contraceptive market, by Application
Male
Female
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Oral Contraceptive manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Oral Contraceptive in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Oral Contraceptive Market Overview
1.1 Oral Contraceptive Product Overview
1.2 Oral Contraceptive Market Segment by Type
1.2.1 Combination
1.2.2 Progestin Only
1.2.3 Others
1.3 Global Oral Contraceptive Market Size by Type
1.3.1 Global Oral Contraceptive Market Size Overview by Type (2018-2029)
1.3.2 Global Oral Contraceptive Historic Market Size Review by Type (2018-2023)
1.3.3 Global Oral Contraceptive Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Oral Contraceptive Sales Breakdown by Type (2018-2023)
1.4.2 Europe Oral Contraceptive Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Oral Contraceptive Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Oral Contraceptive Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Oral Contraceptive Sales Breakdown by Type (2018-2023)
2 Global Oral Contraceptive Market Competition by Company
2.1 Global Top Players by Oral Contraceptive Sales (2018-2023)
2.2 Global Top Players by Oral Contraceptive Revenue (2018-2023)
2.3 Global Top Players by Oral Contraceptive Price (2018-2023)
2.4 Global Top Manufacturers Oral Contraceptive Manufacturing Base Distribution, Sales Area, Product Type
2.5 Oral Contraceptive Market Competitive Situation and Trends
2.5.1 Oral Contraceptive Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Oral Contraceptive Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oral Contraceptive as of 2022)
2.7 Date of Key Manufacturers Enter into Oral Contraceptive Market
2.8 Key Manufacturers Oral Contraceptive Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Oral Contraceptive Status and Outlook by Region
3.1 Global Oral Contraceptive Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Oral Contraceptive Historic Market Size by Region
3.2.1 Global Oral Contraceptive Sales in Volume by Region (2018-2023)
3.2.2 Global Oral Contraceptive Sales in Value by Region (2018-2023)
3.2.3 Global Oral Contraceptive Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Oral Contraceptive Forecasted Market Size by Region
3.3.1 Global Oral Contraceptive Sales in Volume by Region (2024-2029)
3.3.2 Global Oral Contraceptive Sales in Value by Region (2024-2029)
3.3.3 Global Oral Contraceptive Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Oral Contraceptive by Application
4.1 Oral Contraceptive Market Segment by Application
4.1.1 Male
4.1.2 Female
4.2 Global Oral Contraceptive Market Size by Application
4.2.1 Global Oral Contraceptive Market Size Overview by Application (2018-2029)
4.2.2 Global Oral Contraceptive Historic Market Size Review by Application (2018-2023)
4.2.3 Global Oral Contraceptive Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Oral Contraceptive Sales Breakdown by Application (2018-2023)
4.3.2 Europe Oral Contraceptive Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Oral Contraceptive Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Oral Contraceptive Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Oral Contraceptive Sales Breakdown by Application (2018-2023)
5 North America Oral Contraceptive by Country
5.1 North America Oral Contraceptive Historic Market Size by Country
5.1.1 North America Oral Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Oral Contraceptive Sales in Volume by Country (2018-2023)
5.1.3 North America Oral Contraceptive Sales in Value by Country (2018-2023)
5.2 North America Oral Contraceptive Forecasted Market Size by Country
5.2.1 North America Oral Contraceptive Sales in Volume by Country (2024-2029)
5.2.2 North America Oral Contraceptive Sales in Value by Country (2024-2029)
6 Europe Oral Contraceptive by Country
6.1 Europe Oral Contraceptive Historic Market Size by Country
6.1.1 Europe Oral Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Oral Contraceptive Sales in Volume by Country (2018-2023)
6.1.3 Europe Oral Contraceptive Sales in Value by Country (2018-2023)
6.2 Europe Oral Contraceptive Forecasted Market Size by Country
6.2.1 Europe Oral Contraceptive Sales in Volume by Country (2024-2029)
6.2.2 Europe Oral Contraceptive Sales in Value by Country (2024-2029)
7 Asia-Pacific Oral Contraceptive by Region
7.1 Asia-Pacific Oral Contraceptive Historic Market Size by Region
7.1.1 Asia-Pacific Oral Contraceptive Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Oral Contraceptive Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Oral Contraceptive Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Oral Contraceptive Forecasted Market Size by Region
7.2.1 Asia-Pacific Oral Contraceptive Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Oral Contraceptive Sales in Value by Region (2024-2029)
8 Latin America Oral Contraceptive by Country
8.1 Latin America Oral Contraceptive Historic Market Size by Country
8.1.1 Latin America Oral Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Oral Contraceptive Sales in Volume by Country (2018-2023)
8.1.3 Latin America Oral Contraceptive Sales in Value by Country (2018-2023)
8.2 Latin America Oral Contraceptive Forecasted Market Size by Country
8.2.1 Latin America Oral Contraceptive Sales in Volume by Country (2024-2029)
8.2.2 Latin America Oral Contraceptive Sales in Value by Country (2024-2029)
9 Middle East and Africa Oral Contraceptive by Country
9.1 Middle East and Africa Oral Contraceptive Historic Market Size by Country
9.1.1 Middle East and Africa Oral Contraceptive Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Oral Contraceptive Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Oral Contraceptive Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Oral Contraceptive Forecasted Market Size by Country
9.2.1 Middle East and Africa Oral Contraceptive Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Oral Contraceptive Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Pfizer, Inc.
10.1.1 Pfizer, Inc. Company Information
10.1.2 Pfizer, Inc. Introduction and Business Overview
10.1.3 Pfizer, Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer, Inc. Oral Contraceptive Products Offered
10.1.5 Pfizer, Inc. Recent Development
10.2 Bayer AG
10.2.1 Bayer AG Company Information
10.2.2 Bayer AG Introduction and Business Overview
10.2.3 Bayer AG Oral Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Bayer AG Oral Contraceptive Products Offered
10.2.5 Bayer AG Recent Development
10.3 Merck & Co., Inc.
10.3.1 Merck & Co., Inc. Company Information
10.3.2 Merck & Co., Inc. Introduction and Business Overview
10.3.3 Merck & Co., Inc. Oral Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Merck & Co., Inc. Oral Contraceptive Products Offered
10.3.5 Merck & Co., Inc. Recent Development
10.4 Janssen Global Services, LLC
10.4.1 Janssen Global Services, LLC Company Information
10.4.2 Janssen Global Services, LLC Introduction and Business Overview
10.4.3 Janssen Global Services, LLC Oral Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Janssen Global Services, LLC Oral Contraceptive Products Offered
10.4.5 Janssen Global Services, LLC Recent Development
10.5 Mankind Pharma Ltd.
10.5.1 Mankind Pharma Ltd. Company Information
10.5.2 Mankind Pharma Ltd. Introduction and Business Overview
10.5.3 Mankind Pharma Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Mankind Pharma Ltd. Oral Contraceptive Products Offered
10.5.5 Mankind Pharma Ltd. Recent Development
10.6 Teva Pharmaceutical Industries Ltd
10.6.1 Teva Pharmaceutical Industries Ltd Company Information
10.6.2 Teva Pharmaceutical Industries Ltd Introduction and Business Overview
10.6.3 Teva Pharmaceutical Industries Ltd Oral Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Teva Pharmaceutical Industries Ltd Oral Contraceptive Products Offered
10.6.5 Teva Pharmaceutical Industries Ltd Recent Development
10.7 Allergan, plc (Actavis)
10.7.1 Allergan, plc (Actavis) Company Information
10.7.2 Allergan, plc (Actavis) Introduction and Business Overview
10.7.3 Allergan, plc (Actavis) Oral Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Allergan, plc (Actavis) Oral Contraceptive Products Offered
10.7.5 Allergan, plc (Actavis) Recent Development
10.8 Piramal Enterprises Ltd.
10.8.1 Piramal Enterprises Ltd. Company Information
10.8.2 Piramal Enterprises Ltd. Introduction and Business Overview
10.8.3 Piramal Enterprises Ltd. Oral Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Piramal Enterprises Ltd. Oral Contraceptive Products Offered
10.8.5 Piramal Enterprises Ltd. Recent Development
10.9 Beijing Zizhu Pharm
10.9.1 Beijing Zizhu Pharm Company Information
10.9.2 Beijing Zizhu Pharm Introduction and Business Overview
10.9.3 Beijing Zizhu Pharm Oral Contraceptive Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Beijing Zizhu Pharm Oral Contraceptive Products Offered
10.9.5 Beijing Zizhu Pharm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Oral Contraceptive Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Oral Contraceptive Industrial Chain Analysis
11.4 Oral Contraceptive Market Dynamics
11.4.1 Oral Contraceptive Industry Trends
11.4.2 Oral Contraceptive Market Drivers
11.4.3 Oral Contraceptive Market Challenges
11.4.4 Oral Contraceptive Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Oral Contraceptive Distributors
12.3 Oral Contraceptive Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
